Solara Active Pharma Sciences - PP Stock Screener | Share Price & Fundamental Analysis
SOLARAPP1
Pharmaceuticals
Share Price BSE
₹325.75
▲
3.75 (1.16%)
Track Solara Active Pharma Sciences - PP share price live with TickJournal's free stock screener.
Analyze Solara Active Pharma Sciences - PP share price history trends and compare 52-week high low
levels.
Calculate SOLARAPP1 stock fair value using fundamental analysis and view live share price charts.
Determine Solara Active Pharma Sciences - PP share intrinsic value and compare it with current SOLARAPP1 share price.
Record your Solara Active Pharma Sciences - PP trades in TickJournal's free trading journal and track your portfolio performance.
Solara Active Pharma Sciences - PP Market Cap
₹404.13 Cr.
EPS (TTM)
-
Dividend Yield
-
Debt to Equity
-
SOLARAPP1 52 Week High
₹478.90
Solara Active Pharma Sciences - PP 52 Week Low
₹312.75
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
-
Total Equity
-
Solara Active Pharma Sciences - PP Share Price History - Stock Screener Chart
Screen SOLARAPP1 historical share price movements with interactive charts. Analyze price trends and patterns.
Solara Active Pharma Sciences - PP Company Profile - Fundamental Screener
Screen Solara Active Pharma Sciences - PP company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SOLARAPP1 shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
IN9624Z01022
Solara Active Pharma Sciences - PP Balance Sheet Screener
Screen SOLARAPP1 balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
Solara Active Pharma Sciences - PP Income Statement Screener - Profit & Revenue Analysis
Screen Solara Active Pharma Sciences - PP income statement and profit fundamentals.
Analyze SOLARAPP1 quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Solara Active Pharma Sciences - PP share price evaluation.
Solara Active Pharma Sciences - PP Cash Flow Screener - Liquidity Fundamentals
Screen SOLARAPP1 cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
Solara Active Pharma Sciences - PP Shareholding Pattern Screener
See Solara Active Pharma Sciences - PP shareholding pattern with promoter, FII, and DII holdings.
Check Solara Active Pharma Sciences - PP promoter holding and ownership changes for SOLARAPP1 on TickJournal.
Solara Active Pharma Sciences - PP Share Dividend Screener - Share Yield Analysis
Check Solara Active Pharma Sciences - PP dividend history with payout and yield data.
View Solara Active Pharma Sciences - PP dividend details including ex-dates and amounts for SOLARAPP1 stock.
Solara Active Pharma Sciences - PP Stock Index Membership
See which indices include Solara Active Pharma Sciences - PP stock.
Check SOLARAPP1 index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Solara Active Pharma Sciences - PP Market Events Screener - Corporate Actions
Get Solara Active Pharma Sciences - PP corporate actions including splits, bonuses, and buybacks.
Check Solara Active Pharma Sciences - PP stock events that may affect SOLARAPP1 share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 6.67% |
Solara Active Pharma Sciences - PP Competitors Screener - Peer Comparison
Screen SOLARAPP1 competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 411,486 | 37.23 | 54,729 | 9.71% | 10,980 | 53.25 |
| Divis Laboratories | 165,095 | 65.90 | 9,712 | 18.67% | 2,191 | 48.15 |
| Torrent Pharmaceuticals | 143,142 | 63.47 | 11,539 | 6.99% | 1,911 | 70.35 |
| Cipla | 108,904 | 24.16 | 28,410 | 7.12% | 5,291 | 45.95 |
| Dr Reddys Laboratories | 106,507 | 19.18 | 33,741 | 16.73% | 5,725 | 58.53 |
| Lupin | 102,761 | 21.74 | 22,910 | 13.74% | 3,306 | 60.82 |
| Zydus Life Science | 91,215 | 18.22 | 23,511 | 18.55% | 4,615 | 52.96 |
| Mankind Pharma | 85,641 | 47.66 | 12,744 | 20.90% | 2,007 | 45.43 |
| Aurobindo Pharma | 68,982 | 19.75 | 32,346 | 9.43% | 3,484 | 51.95 |
| Alkem Laboratories | 64,906 | 27.05 | 13,458 | 3.70% | 2,216 | 40.44 |
Solara Active Pharma Sciences - PP Company Announcements - News Screener
Screen SOLARAPP1 latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-16 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | View |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-12 | Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended December 31 2025. | View |
| 2026-02-12 | Announcement Under Regulation 30 Of SEBI (LODR) 2015 Regarding The Revision And Adoption Of Policies. | View |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-02-12 | Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended December 31 2025 | View |
| 2026-02-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-04 | Dispatch Of Second Reminder Notice For Payment Of First Call Money | View |
| 2026-02-04 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2026-02-03 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-01-12 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-12-24 | Closure of Trading Window | View |
| 2025-12-17 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2025-12-17 | Reconstitution Of The Management Committee | View |
| 2025-12-17 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2025-12-05 | Announcement under Regulation 30 (LODR)-Resignation of Director | View |